Suppr
超能文献

Chr2 30297612-ALK, A Novel Intergenic Fusion With Exon18 of ALK, Responds to Crizotinib.

作者信息

Chen Xiaofeng, Zhao Guohong, Zhong Peilin, Zhang Min, Chen Rongrong, Zhang Derong

机构信息

Department of Thoracic Surgery, Fujian Province Cancer Hospital, Fuzhou, Fujian, China.

Department of Gynecological Oncology Radiotherapy, Fujian Province Cancer Hospital, Fuzhou, Fujian, China.

出版信息

Clin Lung Cancer. 2020 Nov;21(6):e564-e566. doi: 10.1016/j.cllc.2020.04.014. Epub 2020 May 6.

DOI:10.1016/j.cllc.2020.04.014

PMID:32576444

Abstract

摘要

相似文献

Chr2 30297612-ALK, A Novel Intergenic Fusion With Exon18 of ALK, Responds to Crizotinib.

Clin Lung Cancer. 2020 Nov;21(6):e564-e566. doi: 10.1016/j.cllc.2020.04.014. Epub 2020 May 6.

Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib.

J Thorac Oncol. 2019 Dec;14(12):e266-e268. doi: 10.1016/j.jtho.2019.07.021.

A Novel Intergenic Region between CENPA and DPYSL5-ALK Exon 20 Fusion Variant Responding to Crizotinib Treatment in a Patient with Lung Adenocarcinoma.

J Thorac Oncol. 2019 Sep;14(9):e191-e193. doi: 10.1016/j.jtho.2019.04.012.

Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma.

Clin Lung Cancer. 2019 Sep;20(5):e548-e551. doi: 10.1016/j.cllc.2019.06.001. Epub 2019 Jun 14.

The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma.

Lung Cancer. 2019 Nov;137:19-22. doi: 10.1016/j.lungcan.2019.08.032. Epub 2019 Aug 31.

Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient: A case report.

Thorac Cancer. 2020 Jun;11(6):1695-1698. doi: 10.1111/1759-7714.13389. Epub 2020 Mar 24.

A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib.

Lung Cancer. 2020 Apr;142:59-62. doi: 10.1016/j.lungcan.2020.02.012. Epub 2020 Feb 21.

Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib.

Lung Cancer. 2021 Apr;154:216-218. doi: 10.1016/j.lungcan.2021.02.008. Epub 2021 Feb 16.

Melanoregulin-Anaplastic Lymphoma Kinase (ALK), a Novel ALK Rearrangement That Responds to Crizotinib in Lung Adenocarcinoma.

J Thorac Oncol. 2020 Mar;15(3):e44-e46. doi: 10.1016/j.jtho.2019.11.019.

Attenuated isolated 3' signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC.

Lung Cancer. 2020 May;143:80-85. doi: 10.1016/j.lungcan.2020.03.007. Epub 2020 Mar 10.

引用本文的文献

Novel gene-intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathy.

Brain. 2023 Mar 1;146(3):880-897. doi: 10.1093/brain/awac424.

Effective treatment in lung adenocarcinoma patient with brain metastases harboring novel CLHC1/RNT4 intergenic region- ALK fusion: A case report.

Medicine (Baltimore). 2022 Apr 8;101(14):e29134. doi: 10.1097/MD.0000000000029134.

Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes.

ESMO Open. 2022 Apr;7(2):100405. doi: 10.1016/j.esmoop.2022.100405. Epub 2022 Mar 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Chr2 30297612-ALK, A Novel Intergenic Fusion With Exon18 of ALK, Responds to Crizotinib.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译